AUGUSTINA DEFOE: Open Payments
NPI 1962091710 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 52 payments from 16 companies in 2025. Trend: 2023 $916 · 2024 $1,044 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $290 |
| BridgeBio Pharma, Inc. | 7 | $132 |
| Merck Sharp & Dohme LLC | 8 | $131 |
| Alnylam Pharmaceuticals Inc. | 5 | $117 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Astellas Pharma US Inc | 3 | $69 |
| PFIZER INC. | 4 | $62 |
| AtriCure, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $43 |
Products named: JARDIANCE, Attruby, VERQUVO, AMVUTTRA, Cresemba, VYNDAQEL, ATRICLIP LAA EXCLUSION SYSTEM, LEQVIO.
Industry payments across NJ — which companies pay providers there.
